Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026)
Quantum Biopharma recorded quarterly Enterprise Value of -$2.3 million in Q1 2026, up 44.54% quarter-over-quarter from -$4.2 million in Q4 2025, and up 67.85% year-over-year from -$1.4 million in Q1 2025.
Quantum Biopharma's Enterprise Value history runs 9 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 67.85% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at -$2.3 million (up 67.85% YoY), while the FY2025 annual figure was -$4.2 million, up 49.19% from the prior year.
- Enterprise Value came in at -$2.3 million for Q1 2026 at Quantum Biopharma, up from -$4.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.3 million in Q1 2026 to a low of -$32.0 million in Q2 2022.
- A 5-year average of -$11.1 million and a median of -$7.0 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 87.46% in 2023 and slumped 147.02% in 2025, its largest moves.
- Quantum Biopharma's Enterprise Value stood at -$17.0 million in 2022, then jumped by 82.46% to -$3.0 million in 2023, then sank by 176.56% to -$8.2 million in 2024, then jumped by 49.19% to -$4.2 million in 2025, then surged by 44.54% to -$2.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$2.3 million, -$4.2 million, and -$5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.76 Mn |
| Dec 31, 2025 | -4.19 Mn |
| Sep 30, 2025 | -4.96 Mn |
| Jun 30, 2025 | -2.17 Mn |
| Mar 31, 2025 | -7.22 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -251,592.00 |
| Jun 30, 2024 | -3.21 Mn |
| Mar 31, 2024 | -2.92 Mn |
| Sep 30, 2023 | -4.46 Mn |
| Jun 30, 2023 | -6.22 Mn |
| Mar 31, 2023 | -9.87 Mn |
| Dec 31, 2022 | -16.98 Mn |
| Sep 30, 2022 | -35.62 Mn |
| Jun 30, 2022 | -35.25 Mn |
| Mar 31, 2022 | -29.11 Mn |
| Dec 31, 2021 | -35.42 Mn |
| Sep 30, 2021 | -19.02 Mn |
| Jun 30, 2021 | -45.45 Mn |
| Mar 31, 2021 | -52.48 Mn |
| Dec 31, 2020 | -17.52 Mn |
| Sep 30, 2020 | -7.15 Mn |
| Jun 30, 2020 | -5.72 Mn |
| Mar 31, 2020 | -6.23 Mn |
| Dec 31, 2019 | -14.93 Mn |
| Mar 31, 2019 | -15.89 Mn |
| Dec 31, 2018 | -16.01 Mn |